| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.006 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.006 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.16 | 0.007 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.007 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.29 | 0.007 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.33 | 0.008 |